BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18975313)

  • 1. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
    Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
    Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis.
    Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S
    Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis.
    Hirata H; Arima M; Fukushima Y; Ishii Y; Tokuhisa T; Fukuda T
    Respirology; 2008 Nov; 13(6):788-98. PubMed ID: 18811877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
    Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
    Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats.
    Li HP; Li X; He GJ; Yi XH; Kaplan AP
    Respirology; 2004 Mar; 9(1):25-32. PubMed ID: 14982598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis.
    Hamaguchi Y; Nishizawa Y; Yasui M; Hasegawa M; Kaburagi Y; Komura K; Nagaoka T; Saito E; Shimada Y; Takehara K; Kadono T; Steeber DA; Tedder TF; Sato S
    Am J Pathol; 2002 Nov; 161(5):1607-18. PubMed ID: 12414509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of thrombin in bleomycin-induced pulmonary fibrosis.
    Tani K; Yasuoka S; Ogura T
    Tokushima J Exp Med; 1990 Jun; 37(1-2):39-48. PubMed ID: 1701928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
    Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
    Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
    Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
    J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
    Wang SJ; Bai W; Wang CL; Dai Z
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of thrombin on lung fibroblast growth and fibrosis in bleomycin-induced lung disorder].
    Tani K; Yasuoka S; Ogushi F; Asada K; Fujisawa K; Ozaki T; Ogura T; Suzuki K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):211-9. PubMed ID: 1709710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies on the pathogenesis and development of interstitial pneumonia and pulmonary fibrosis].
    Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):445-7. PubMed ID: 2477577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.